Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury

被引：0
|
作者：
Heikrujam Nilkanta Meitei
Anupama Pandey
Reena Haobam
机构：
[1] Manipur University,Department of Biotechnology
来源：
Molecular Biology Reports | 2023年 / 50卷
关键词：
AT-DILI; Polymorphisms; Drug metabolism genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2893 / 2900
页数：7
相关论文
共 50 条
  • [21] Genetic Association Studies in Drug-Induced Liver Injury
    Daly, Ann K.
    Day, Chris P.
    SEMINARS IN LIVER DISEASE, 2009, 29 (04) : 400 - 411
  • [22] Genetic and Epigenetic Basis of Drug-Induced Liver Injury
    Singh, Snigdha
    Kumar, P. V. S. N. Kiran
    Kumar, J. Pradeep
    Tomo, Sojit
    Yadav, Dharamveer
    Sharma, Praveen
    Rao, Mahadev
    Banerjee, Mithu
    SEMINARS IN LIVER DISEASE, 2023, 43 (02) : 163 - 175
  • [23] Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens
    Nicoletti, Paola
    Devarbhavi, Harshad
    Goel, Ashish
    Venkatesan, Radha
    Eapen, Chundamannil E.
    Grove, Jane, I
    Zafer, Samreen
    Bjornsson, Einar
    Lucena, M. Isabel
    Andrade, Raul J.
    Pirmohamed, Munir
    Wadelius, Mia
    Larrey, Dominique
    Maitland-van der Zee, Anke-Hilse
    Ibanez, Luisa
    Watkins, Paul B.
    Daly, Ann K.
    Aithal, Guruprasad P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (04) : 1125 - 1135
  • [24] Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population
    Ricardo Oliveira Fernandes, Debora Christina
    Carneiro Santos, Ney Pereira
    Moraes, Milene Raiol
    Oliveira Braga, Ana Cristina
    Silva, Cleonardo Augusto
    Ribeiro-dos-Santos, Andrea
    Santos, Sidney
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 33 : 28 - 31
  • [25] Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
    Meunier, Lucy
    Larrey, Dominique
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [26] Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury
    Daly, Ann K.
    LIVER INTERNATIONAL, 2025, 45 (01)
  • [27] Tailored drug therapy for mitigating drug-induced liver injury: is this the era of genetic screening?
    Huang, Yi-Shin
    PERSONALIZED MEDICINE, 2010, 7 (01) : 5 - 8
  • [28] Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case-Control Study
    He, Lei
    Gao, Li
    Shi, Zhe
    Li, Yuhong
    Zhu, Lingyan
    Li, Shiming
    Zhang, Peng
    Zheng, Guoying
    Ren, Qi
    Li, Yun
    Hu, Bo
    Feng, Fumin
    PLOS ONE, 2015, 10 (03):
  • [29] Drug interaction with Udp-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
    Olubamiwa, AyoOluwa O.
    Liao, Tsung-Jen
    Zhao, Jinwen
    Dehanne, Patrice
    Noban, Catherine
    Angin, Yeliz
    Barberan, Olivier
    Chen, Minjun
    HEPATOLOGY, 2024, : 1512 - 1521
  • [30] Pyrazinamide related prolonged drug-induced liver injury: A case report
    Wang, Yeh-Chin
    Chen, Kai-Hsiang
    Chen, Yen-Lin
    Lin, Shu-Wen
    Liu, Wang-Da
    Wang, Jann-Tay
    Hung, Chien-Ching
    MEDICINE, 2022, 101 (39) : E30955
12345